We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+7.41%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.01%
AUM
$350B
AUM Growth
+$21.2B
Cap. Flow
+$2.73B
Cap. Flow %
0.78%
Top 10 Hldgs %
19.01%
Holding
3,760
New
210
Increased
2,215
Reduced
1,001
Closed
151
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XLO icon
3501
Xilio Therapeutics
XLO
$59.8M
$31.2K ﹤0.01%
+852
New +$36.2K
RLMD icon
3502
Relmada Therapeutics
RLMD
$540M
$30.8K ﹤0.01%
12,505
-61,410
-83% -$170K
ALGS icon
3503
Aligos Therapeutics
ALGS
$26.3M
$30.5K ﹤0.01%
+1,255
New +$33.7K
ORKA
3504
Oruka Therapeutics
ORKA
$5.31B
$30.4K ﹤0.01%
1,249
BMTX
3505
DELISTED
BM Technologies, Inc.
BMTX
$30.4K ﹤0.01%
10,210
CDTX
3506
DELISTED
Cidara Therapeutics
CDTX
$30.3K ﹤0.01%
1,341
PHUN icon
3507
Phunware
PHUN
$42.9M
$30K ﹤0.01%
1,110
MLSS icon
3508
Milestone Scientific
MLSS
$33.3M
$29.9K ﹤0.01%
+34,400
New +$31K
DMTK
3509
DELISTED
DermTech, Inc. Common Stock
DMTK
$29.9K ﹤0.01%
11,512
STIM icon
3510
Neuronetics
STIM
$127M
$29.8K ﹤0.01%
13,837
ADTH
3511
DELISTED
AdTheorent Holding Co
ADTH
$29.4K ﹤0.01%
21,011
-80,170
-79% -$122K
OPTT icon
3512
Ocean Power Technologies
OPTT
$41.5M
$29.2K ﹤0.01%
48,625
SND icon
3513
Smart Sand
SND
$179M
$28.6K ﹤0.01%
17,439
WWR icon
3514
Westwater Resources
WWR
$49.7M
$28.3K ﹤0.01%
34,475
MTNB icon
3515
Matinas BioPharma
MTNB
$1.91M
$28.2K ﹤0.01%
1,568
GNPX icon
3516
Genprex
GNPX
$3.6M
$28.2K ﹤0.01%
1
EXPR
3517
DELISTED
Express, Inc.
EXPR
$28.2K ﹤0.01%
2,376
-7,058
-75% -$102K
DARE icon
3518
Dare Bioscience
DARE
$17.4M
$27.8K ﹤0.01%
2,544
OESX icon
3519
Orion Energy Systems
OESX
$38.9M
$27.7K ﹤0.01%
1,699
AQMS icon
3520
Aqua Metals
AQMS
$9.78M
$27.7K ﹤0.01%
118
SMSI icon
3521
Smith Micro Software
SMSI
$13.6M
$27.4K ﹤0.01%
618
RZLT icon
3522
Rezolute
RZLT
$453M
$27.2K ﹤0.01%
13,757
ALZN icon
3523
Alzamend Neuro
ALZN
$6.42M
$27.1K ﹤0.01%
39
DTIL icon
3524
Precision BioSciences
DTIL
$178M
$27K ﹤0.01%
1,709
XPL icon
3525
Solitario Resources
XPL
$66.3M
$25.8K ﹤0.01%
44,899

Similar funds

Charles Schwab's Q2 2023 Portfolio in Review

As of Q2 2023, Charles Schwab held 3,760 positions worth $350B, up 6.4% from $329B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Charles Schwab's Q2 2023 filing shows 210 new, 2,215 increased, 1,001 reduced and 151 closed positions. Its largest new stake was iShares US Treasury Bond ETF: 7,510,883 shares worth $172M. The largest sale was Broadcom, an estimated $430M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

  • Charles Schwab's largest Q2 2023 buy was iShares US Treasury Bond ETF: 7,510,883 shares worth $172M.
  • Charles Schwab added most to State Street Technology Select Sector SPDR ETF in Q2 2023, an estimated $304M increase.
  • Charles Schwab's biggest Q2 2023 reduction was Broadcom, cutting an estimated $430M.
  • Charles Schwab fully exited iShares 0-1 Year Treasury Bond ETF in Q2 2023, selling an estimated $361M.
  • Charles Schwab's ten largest holdings make up 19% of its $350B portfolio in Q2 2023.
  • Charles Schwab opened 210 new positions and closed 151 in Q2 2023.
  • Charles Schwab's portfolio value rose 6.4% quarter-over-quarter to $350B.

Based on Charles Schwab's 13F filing for Q2 2023, filed 10 Aug 2023.